Dashboard
Manage Tickers

PFE PFIZER INC

NYSE pfizer.com


$ 24.32 $ -0.36 (-1.46 %)    

Tuesday, 04-Nov-2025 18:17:31 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 618.08 $ -12.83 (-2.03 %)
DIA $ 471.46 $ -2.57 (-0.54 %)
SPY $ 674.84 $ -8.10 (-1.19 %)
TLT $ 89.95 $ 0.20 (0.22 %)
GLD $ 362.02 $ -6.46 (-1.75 %)
$ 24.3
$ 24.39
$ 24.31 x 8
$ 24.34 x 100
$ 24.20 - $ 25.20
$ 20.18 - $ 27.69
163,541,212
na
138.16B
$ 0.50
$ 14.06
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-28-2025 10-Q
2 08-05-2025 06-29-2025 10-Q
3 05-05-2025 03-30-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-04-2024 09-29-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-22-2024 12-31-2023 10-K
9 11-08-2023 10-01-2023 10-Q
10 08-09-2023 07-02-2023 10-Q
11 05-10-2023 04-02-2023 10-Q
12 02-23-2023 12-31-2022 10-K
13 11-09-2022 10-02-2022 10-Q
14 08-10-2022 07-03-2022 10-Q
15 05-11-2022 04-03-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-12-2021 10-03-2021 10-Q
18 08-12-2021 07-04-2021 10-Q
19 05-13-2021 04-04-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-27-2020 10-Q
22 08-06-2020 06-28-2020 10-Q
23 05-07-2020 03-29-2020 10-Q
24 02-27-2020 12-31-2019 10-K
25 11-07-2019 09-29-2019 10-Q
26 08-08-2019 06-30-2019 10-Q
27 05-09-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 07-01-2018 10-Q
31 05-10-2018 04-01-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 11-09-2017 10-01-2017 10-Q
34 08-10-2017 07-02-2017 10-Q
35 05-11-2017 04-02-2017 10-Q
36 02-23-2017 12-31-2016 10-K
37 11-10-2016 10-02-2016 10-Q
38 08-11-2016 07-03-2016 10-Q
39 05-12-2016 04-03-2016 10-Q
40 02-29-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

novo-pfizer-are-battling-to-buy-the-future-of-weight-loss--but-viking-already-owns-it
Novo, Pfizer Are Battling To Buy The Futur...
11/04/2025 20:04:42

Viking Global's $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nor...

pfizer-novo-nordisk-intensify-fight-for-metsera-as-buyout-offers-continue-to-climb
Pfizer, Novo Nordisk Intensify Fight For M...
11/04/2025 19:45:55

Novo Nordisk boosts its Metsera bid to $62.20 per share, valuing the company at $10 billion and outbidding Pfizer in the escala...

pfizer-q3-revenue-trends-remain-uneven-cost-cuts-drive-earnings
Pfizer Q3 Revenue Trends Remain Uneven, Co...
11/04/2025 18:25:49

Pfizer revenue trends remained uneven in the third quarter, the company exhibited "continued cost discipline," accordin...

palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday
Palantir Weighs On Wall Street, Bitcoin Sl...
11/04/2025 18:22:32

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

Core News & Articles
Pfizer CEO Says Our Bid For Metsera Has Ta...
11/04/2025 15:52:10

-Reuters Citing Conf. Call

dow-dips-over-400-points-pfizer-earnings-top-estimates
Dow Dips Over 400 Points; Pfizer Earnings ...
11/04/2025 14:53:19

pfizers-core-drugs-offset-covid-revenue-drop-lifts-2025-profit-outlook-despite-tariffs
Pfizer's Core Drugs Offset COVID Revenue D...
11/04/2025 14:22:21

Pfizer beat Q3 estimates with 87 cents EPS, raised 2025 profit guidance, as Eliquis and Vyndaqel growth offset declining COVID ...

Core News & Articles
Pursuant To Pfizer Merger Agreement, Metse...
11/04/2025 14:12:57

Core News & Articles
Metsera Receives Amended Proposal From Nov...
11/04/2025 14:11:56

pfizer-q3-revenues-higher-for-eliquis-vyndaqel-and-nurtec-odtvydura-offset-by-lower-revenues-for-paxlovid-and-comirnaty
Pfizer Q3 Revenues Higher For Eliquis, Vyn...
11/04/2025 11:48:54

pfizer-raises-fy2025-adj-eps-guidance-from-290-310-to-300-315-vs-304-est-affirms-fy2025-sales-guidance-of-61000b-64000b-vs-62879b-est
Pfizer Raises FY2025 Adj EPS Guidance from...
11/04/2025 11:45:49

Pfizer (NYSE:PFE) raises FY2025 Adj EPS guidance from $2.90-$3.10 to $3.00-$3.15 vs $3.04 analyst estimate. Affirms FY2025 sale...

pfizer-q3-adj-eps-087-beats-063-estimate-sales-16654b-beat-16592b-estimate
Pfizer Q3 Adj. EPS $0.87 Beats $0.63 Estim...
11/04/2025 11:45:21

Pfizer (NYSE:PFE) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.63 by 38.31 pe...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

pfizer-gears-up-for-q3-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts
Pfizer Gears Up For Q3 Print; Here Are The...
11/04/2025 07:49:05

uber-amd-and-3-stocks-to-watch-heading-into-tuesday
Uber, AMD And 3 Stocks To Watch Heading In...
11/04/2025 07:27:15

Stock futures trading lower, watch Uber, Upwork, AMD, Starbucks, Pfizer earnings. Starbucks forms China JV. Cramer advises agai...

michael-burry-is-super-bearish-on-palantir--with-5-million-puts
Michael Burry Is Super-Bearish On Palantir...
11/03/2025 23:17:30

Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, am...

Core News & Articles
Delaware Judge Schedules Tuesday Hearing O...
11/03/2025 22:03:22

 - Reuters Citing Court Filing

check-out-what-whales-are-doing-with-pfe
Check Out What Whales Are Doing With PFE
11/03/2025 17:02:57

Core News & Articles
Novo Nordisk Spokesperson Says Pfizer's Cl...
11/03/2025 16:52:11

- Reuters

Core News & Articles
Novo Nordisk Says Our Proposal Offers Comp...
11/03/2025 16:16:10

- Reuters

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION